| CLK1 | CLK | CMGC | 6z4z | B | A | 7,10-dioxa-13,17,18,21-tetrazatetracyclo[12.5.2.12,6.017,20]docosa-1(20),2(22),3,5,14(21),15,18-heptaene-5-carboxylic acid | Human | 12310 | 0.62 | |
| ACVR1 (ALK2) | STKR | TKL | 5oy6 | C | | cyclical inhibitor od36 | Human | 8529 | 1.00 | |
| CLK1 | CLK | CMGC | 6z4z | A | B | 7,10-dioxa-13,17,18,21-tetrazatetracyclo[12.5.2.12,6.017,20]docosa-1(20),2(22),3,5,14(21),15,18-heptaene-5-carboxylic acid | Human | 12312 | 0.62 | |
| HASPIN (Haspin) | Haspin | Other | 6z59 | A | A | 11-oxa-8,14,18,19,22-pentazatetracyclo[13.5.2.12,6.018,21]tricosa-1(21),2,4,6(23),15(22),16,19-heptaen-7-one | Human | 12326 | 0.60 | |
| HASPIN (Haspin) | Haspin | Other | 6z5d | A | A | 11-methyl-8,11,14,18,19,22-hexazatetracyclo[13.5.2.12,6.018,21]tricosa-1(21),2(23),3,5,15(22),16,19-heptaen-7-one | Human | 12325 | 0.45 | |
| HASPIN (Haspin) | Haspin | Other | 6z58 | A | A | 8,14,18,19,22-pentazatetracyclo[13.5.2.12,6.018,21]tricosa-1(21),2,4,6(23),15(22),16,19-heptaen-7-one | Human | 12327 | 0.46 | |
| ACVR1 (ALK2) | STKR | TKL | 5oy6 | B | | cyclical inhibitor od36 | Human | 8531 | 1.00 | |
| HASPIN (Haspin) | Haspin | Other | 6z5d | A | B | 11-methyl-8,11,14,18,19,22-hexazatetracyclo[13.5.2.12,6.018,21]tricosa-1(21),2(23),3,5,15(22),16,19-heptaen-7-one | Human | 12330 | 0.45 | |
| HASPIN (Haspin) | Haspin | Other | 6z58 | A | B | 8,14,18,19,22-pentazatetracyclo[13.5.2.12,6.018,21]tricosa-1(21),2,4,6(23),15(22),16,19-heptaen-7-one | Human | 12332 | 0.46 | |
| CLK1 | CLK | CMGC | 6z4z | C | A | 7,10-dioxa-13,17,18,21-tetrazatetracyclo[12.5.2.12,6.017,20]docosa-1(20),2(22),3,5,14(21),15,18-heptaene-5-carboxylic acid | Human | 12309 | 0.62 | |
| HASPIN (Haspin) | Haspin | Other | 6z59 | A | B | 11-oxa-8,14,18,19,22-pentazatetracyclo[13.5.2.12,6.018,21]tricosa-1(21),2,4,6(23),15(22),16,19-heptaen-7-one | Human | 12316 | 0.60 | |
| HASPIN (Haspin) | Haspin | Other | 6z5c | A | B | 7,10-dioxa-13,17,18,21-tetrazatetracyclo[12.5.2.12,6.017,20]docosa-1(20),2(22),3,5,14(21),15,18-heptaene-5-carboxylic acid | Human | 12318 | 0.62 | |
| CLK3 | CLK | CMGC | 6z55 | A | C | 7,10-dioxa-13,17,18,21-tetrazatetracyclo[12.5.2.12,6.017,20]docosa-1(20),2(22),3,5,14(21),15,18-heptaene-5-carboxylic acid | Human | 12301 | 0.62 | |
| CLK1 | CLK | CMGC | 6z4z | C | B | 7,10-dioxa-13,17,18,21-tetrazatetracyclo[12.5.2.12,6.017,20]docosa-1(20),2(22),3,5,14(21),15,18-heptaene-5-carboxylic acid | Human | 12313 | 0.62 | |
| CLK3 | CLK | CMGC | 6z55 | B | C | 7,10-dioxa-13,17,18,21-tetrazatetracyclo[12.5.2.12,6.017,20]docosa-1(20),2(22),3,5,14(21),15,18-heptaene-5-carboxylic acid | Human | 12297 | 0.62 | |
| CLK3 | CLK | CMGC | 6z55 | A | B | 7,10-dioxa-13,17,18,21-tetrazatetracyclo[12.5.2.12,6.017,20]docosa-1(20),2(22),3,5,14(21),15,18-heptaene-5-carboxylic acid | Human | 12298 | 0.62 | |
| CLK3 | CLK | CMGC | 6z55 | B | B | 7,10-dioxa-13,17,18,21-tetrazatetracyclo[12.5.2.12,6.017,20]docosa-1(20),2(22),3,5,14(21),15,18-heptaene-5-carboxylic acid | Human | 12299 | 0.62 | |
| CLK3 | CLK | CMGC | 6z55 | B | A | 7,10-dioxa-13,17,18,21-tetrazatetracyclo[12.5.2.12,6.017,20]docosa-1(20),2(22),3,5,14(21),15,18-heptaene-5-carboxylic acid | Human | 12303 | 0.62 | |
| CLK3 | CLK | CMGC | 6z55 | A | A | 7,10-dioxa-13,17,18,21-tetrazatetracyclo[12.5.2.12,6.017,20]docosa-1(20),2(22),3,5,14(21),15,18-heptaene-5-carboxylic acid | Human | 12302 | 0.62 | |
| STK17A (DRAK1) | DAPK | CAMK | 7quf | A | | ~{n}-~{tert}-butyl-7,10-dioxa-13,17,18,21-tetrazatetracyclo[12.5.2.1^{2,6}.0^{17,20}]docosa-1(20),2(22),3,5,14(21),15,18-heptaene-5-carboxamide | Human | 14093 | 0.57 | |
| STK17A (DRAK1) | DAPK | CAMK | 7que | A | | ~{n}-(phenylmethyl)-7,10-dioxa-13,17,18,21-tetrazatetracyclo[12.5.2.1^{2,6}.0^{17,20}]docosa-1(20),2(22),3,5,14(21),15,18-heptaene-5-carboxamide | Human | 14094 | 0.53 | |
| ACVR1 (ALK2) | STKR | TKL | 5oy6 | D | | cyclical inhibitor od36 | Human | 8534 | 1.00 | |
| CLK1 | CLK | CMGC | 6z4z | B | B | 7,10-dioxa-13,17,18,21-tetrazatetracyclo[12.5.2.12,6.017,20]docosa-1(20),2(22),3,5,14(21),15,18-heptaene-5-carboxylic acid | Human | 12311 | 0.62 | |
| CLK1 | CLK | CMGC | 6z4z | A | A | 7,10-dioxa-13,17,18,21-tetrazatetracyclo[12.5.2.12,6.017,20]docosa-1(20),2(22),3,5,14(21),15,18-heptaene-5-carboxylic acid | Human | 12315 | 0.62 | |
| ACVR1 (ALK2) | STKR | TKL | 5oy6 | A | | cyclical inhibitor od36 | Human | 8532 | 1.00 | |
| CSNK2A1 (CK2a1) | CK2 | CMGC | 6yul | A | | 7,10-dioxa-13,17,18,21-tetrazatetracyclo[12.5.2.12,6.017,20]docosa-1(20),2(22),3,5,14(21),15,18-heptaene-5-carboxylic acid | Human | 12458 | 0.62 | |
| HASPIN (Haspin) | Haspin | Other | 6z57 | A | A | 10-(2-morpholin-4-ylethyl)-7-oxa-10,13,17,18,21-pentazatetracyclo[12.5.2.12,6.017,20]docosa-1(20),2(22),3,5,14(21),15,18-heptaene | Human | 12321 | 0.50 | |
| HASPIN (Haspin) | Haspin | Other | 6z57 | A | B | 10-(2-morpholin-4-ylethyl)-7-oxa-10,13,17,18,21-pentazatetracyclo[12.5.2.12,6.017,20]docosa-1(20),2(22),3,5,14(21),15,18-heptaene | Human | 12323 | 0.50 | |
| HASPIN (Haspin) | Haspin | Other | 6z5c | A | A | 7,10-dioxa-13,17,18,21-tetrazatetracyclo[12.5.2.12,6.017,20]docosa-1(20),2(22),3,5,14(21),15,18-heptaene-5-carboxylic acid | Human | 12319 | 0.62 | |
| STK10 (LOK) | STE20 | STE | 7qgp | A | | 1-[(4-chloranyl-2-methyl-phenyl)methyl]-3-(7,10-dioxa-13,17,18,21-tetrazatetracyclo[12.5.2.1^{2,6}.0^{17,20}]docosa-1(20),2(22),3,5,14(21),15,18-heptaen-5-yl)urea | Human | 14075 | 0.53 | |
